NO990792D0 - FremgangsmÕte for inhibering av ekspresjonen av FAS - Google Patents

FremgangsmÕte for inhibering av ekspresjonen av FAS

Info

Publication number
NO990792D0
NO990792D0 NO990792A NO990792A NO990792D0 NO 990792 D0 NO990792 D0 NO 990792D0 NO 990792 A NO990792 A NO 990792A NO 990792 A NO990792 A NO 990792A NO 990792 D0 NO990792 D0 NO 990792D0
Authority
NO
Norway
Prior art keywords
fas
inhibiting
expression
Prior art date
Application number
NO990792A
Other languages
English (en)
Other versions
NO990792L (no
Inventor
Giora Zeev Feuerstein
Tian-Li Yue
Original Assignee
Boehringer Mannheim Pharm Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Pharm Corp filed Critical Boehringer Mannheim Pharm Corp
Publication of NO990792D0 publication Critical patent/NO990792D0/no
Publication of NO990792L publication Critical patent/NO990792L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Separation By Low-Temperature Treatments (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Fats And Perfumes (AREA)
NO990792A 1996-08-23 1999-02-19 FremgangsmÕte for inhibering av ekspresjonen av FAS NO990792L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2448696P 1996-08-23 1996-08-23
PCT/US1997/014792 WO1998007321A1 (en) 1996-08-23 1997-08-22 Method for inhibiting the expression of fas

Publications (2)

Publication Number Publication Date
NO990792D0 true NO990792D0 (no) 1999-02-19
NO990792L NO990792L (no) 1999-04-15

Family

ID=21820837

Family Applications (1)

Application Number Title Priority Date Filing Date
NO990792A NO990792L (no) 1996-08-23 1999-02-19 FremgangsmÕte for inhibering av ekspresjonen av FAS

Country Status (17)

Country Link
US (1) US6096777A (no)
EP (1) EP0924985A4 (no)
JP (1) JP2001504804A (no)
KR (1) KR20000068322A (no)
CN (1) CN1233150A (no)
AU (1) AU4083097A (no)
BR (1) BR9711228A (no)
CA (1) CA2264178A1 (no)
CZ (1) CZ59199A3 (no)
HU (1) HUP9904243A3 (no)
IL (1) IL128613A (no)
NO (1) NO990792L (no)
NZ (1) NZ334307A (no)
PL (1) PL331766A1 (no)
TR (1) TR199900370T2 (no)
WO (1) WO1998007321A1 (no)
ZA (1) ZA977565B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2183870C2 (ru) * 2001-06-26 2002-06-20 Байков Юрий Александрович Устройство для защиты от излучения радиотелефонной трубки
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
JP2006500320A (ja) * 2002-04-30 2006-01-05 エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド カルベジロール一クエン酸塩一水和物
AU2003251627A1 (en) * 2002-06-27 2004-01-19 Sb Pharmco Puerto Rico Inc. Carvedilol hydrobromide
MXPA04012923A (es) * 2002-06-27 2005-03-31 Sb Pharmco Inc Sales de fosfato de carvedilol y/o solvatos de las mismas, composiciones correspondientes y/o metodos de tratamiento.
US6632832B1 (en) 2002-09-10 2003-10-14 Dabur Research Foundation Anti-cancer activity of carvedilol and its isomers
AU2002336473A1 (en) * 2002-09-10 2004-04-30 Dabur Research Foundation Anti-cancer activity of carvedilol and its isomers
JP2007512372A (ja) * 2003-11-25 2007-05-17 エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド カルベジロール塩、対応する組成物、送達および／または治療方法
WO2005051322A2 (en) * 2003-11-25 2005-06-09 Sb Pharmco Puerto Rico Inc. Controlled release pharmaceutical formulations comprising carvedilol, free based and its salts
US20050169994A1 (en) * 2003-11-25 2005-08-04 Burke Matthew D. Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
CA2625219A1 (en) 2005-10-13 2007-04-19 Orchid Research Laboratories Limited Heterocyclic compounds as pstat3/il-6 inhibitors
JP2012051804A (ja) * 2008-12-26 2012-03-15 Kyoto Univ Ｅｇ５阻害剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2815926A1 (de) * 1978-04-13 1979-10-18 Boehringer Mannheim Gmbh Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US5393772A (en) * 1993-11-24 1995-02-28 Boehringer Mannheim Pharmaceuticals Corporation Use of, and method of treatment using, hydroxycarbazole compounds for inhibition of smooth muscle migration and proliferation

Also Published As

Publication number Publication date
CA2264178A1 (en) 1998-02-26
EP0924985A4 (en) 2000-12-06
NZ334307A (en) 2000-11-24
IL128613A0 (en) 2000-01-31
NO990792L (no) 1999-04-15
HUP9904243A2 (hu) 2000-05-28
CZ59199A3 (cs) 1999-08-11
ZA977565B (en) 1999-02-17
HUP9904243A3 (en) 2001-09-28
EP0924985A1 (en) 1999-06-30
JP2001504804A (ja) 2001-04-10
BR9711228A (pt) 2000-01-11
WO1998007321A1 (en) 1998-02-26
TR199900370T2 (xx) 1999-05-21
US6096777A (en) 2000-08-01
IL128613A (en) 2004-07-25
AU4083097A (en) 1998-03-06
KR20000068322A (ko) 2000-11-25
CN1233150A (zh) 1999-10-27
PL331766A1 (en) 1999-08-02

Similar Documents

Publication Publication Date Title
NO974554L (no) FremgangsmÕte for behandling av en underjordisk formasjon
NO983405L (no) Fremgangsmåte for ökning av smöreevnen til snöskigrunnflater
FI965268A0 (fi) Menetelmä moniarvoisten alkoholien valmistamiseksi
NO983284D0 (no) Antikoagolante midler egnet i behandling av trombose
ID20637A (id) Metode untuk menghambat pembentukan sulfida biogenik
FI950800L (fi) Menetelmä heterosyklisten yhdisteiden sulfinyloimiseksi
FI945441A7 (fi) Uusi menetelmä 7beta-substituoitu-4-atsa-5alfa-androstan-3-onien valmi stamiseksi
NO971213L (no) Fremgangsmåte for modellering av beliggenheten av diskontinuiteter
NO990792L (no) FremgangsmÕte for inhibering av ekspresjonen av FAS
ID18300A (id) Metoda penemperan
NO996432D0 (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
IS4285A (is) Aðferð við að hindra útfellingu
FI971675A7 (fi) Menetelmä bradykiniinin liittyvien tilojen inhiboimiseksi
EE9900404A (et) Arüülaminotriasolopüridiinide valmistamise meetod
FI955110L (fi) Menetelmä massan sakeuden lisäämiseksi
NO20003077L (no) FremgangsmÕte for fremstilling av klorbenzooksazolen
NO20002476L (no) FremgangsmÕte for fremstilling av formylimidazoler
UA25365A (uk) Спосіб профілактики вториhhої катаракти
FI953181A0 (fi) Puriinien valmistusmenetelmä
HK1020839A (en) Method for inhibiting the expression of fas
UA25353A (uk) Спосіб холецистостомії
UA25398A (uk) Спосіб комбіhоваhої холецистолітотомії
UA25135A (uk) Спосіб гастроєюhопластики
FI963726A0 (fi) Foerfarande foer anordnande av en transaktionsbaserad faktvering i samband med telefontjaenster
SE9300381D0 (sv) Foerfaringssaett vid desinficering av vatten

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application